Abstracts 2017

O1-17. Combining anti TNF-α and vedolizumab in the treatment of inflammatory bowel

O2-17. Determinants of optimal bowel function in restorative proctocolectomy – physiological differences contributing to pouch function

O3-17. Mesenchymal stromal cells and their effects on the renin-angiotensin system in dextran sodium sulfate colitis

O4-17. Ankylosing spondylitis and axial spondyloarthritis in patients with long-term inflammatory bowel disease

O5-17. Biologic therapy and surgery in inflammatory bowel disease: Regional differences in Norway

P1-17. The cost-effectiveness of ustekinumab in moderate to severely active Crohn’s disease in Sweden and Norway

P2-17. High prevalence of coeliac disease in a population-based childhood-onset IBD cohort from northern Stockholm County?

P3-17. Is there an association between pain severity and vitamin D deficiency in IBD?

P4-17. Does a defunctioning loop ileostomy make restorative proctocolectomy safer? A retrospective case series review

P5-17. Oral Health Status of Ulcerative Colitis Patients: A Comparative Study

P6-17. Correlation between azathioprine metabolites concentrations and adverse events in patients with Inflammatory bowel disease